sellModerate cluster of 610b5-1 plan
Tien Tzuo sold $1.1M of ZUO
Chairman and CEO at ZUORA INC. 121,822 shares at an average of $9.03, traded Jul 11, 2024, filed Jul 15, 2024.
Warning score
50Value
$1.1M
121,822 shares
Holdings after
6,352
-346% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- +25Trade size$1.1M at market
- +20Share of holdings soldSold 100% of holdings
- +15Cluster6 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0001423774-24-000220, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Jul 11, 2024 | MOption exercise Class A Common Stock10b5-1 | +28,891 | $0.00 | $0 | 35,243 | Jul 15, 2024 |
| Jul 11, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -28,891 | $9.00 | $260k | 6,352 | Jul 15, 2024 |
| Jul 12, 2024 | MOption exercise Class A Common Stock10b5-1 | +11,200 | $0.00 | $0 | 17,552 | Jul 15, 2024 |
| Jul 12, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -11,200 | $9.00 | $101k | 6,352 | Jul 15, 2024 |
| Jul 15, 2024 | MOption exercise Class A Common Stock10b5-1 | +81,731 | $0.00 | $0 | 88,083 | Jul 15, 2024 |
| Jul 15, 2024 | SOpen-market sale Class A Common Stock10b5-1 | -81,731 | $9.05 | $740k | 6,352 | Jul 15, 2024 |
| Jul 11, 2024 | MOption exercise Stock Option (Right to buy Class B Common Stock)derivative10b5-1 | -28,891 | $0.00 | $0 | 825,269 | Jul 15, 2024 |
| Jul 11, 2024 | MOption exercise Class B Common Stockderivative10b5-1 | +28,891 | $0.00 | $0 | 28,891 | Jul 15, 2024 |
| Jul 11, 2024 | CConversion Class B Common Stockderivative10b5-1 | -28,891 | $0.00 | $0 | 0 | Jul 15, 2024 |
| Jul 12, 2024 | MOption exercise Stock Option (Right to buy Class B Common Stock)derivative10b5-1 | -11,200 | $0.00 | $0 | 814,069 | Jul 15, 2024 |
| Jul 12, 2024 | MOption exercise Class B Common Stockderivative10b5-1 | +11,200 | $0.00 | $0 | 11,200 | Jul 15, 2024 |
| Jul 12, 2024 | CConversion Class B Common Stockderivative10b5-1 | -11,200 | $0.00 | $0 | 0 | Jul 15, 2024 |
| Jul 15, 2024 | MOption exercise Stock Option (Right to buy Class B Common Stock)derivative10b5-1 | -81,731 | $0.00 | $0 | 732,338 | Jul 15, 2024 |
| Jul 15, 2024 | MOption exercise Class B Common Stockderivative10b5-1 | +81,731 | $0.00 | $0 | 81,731 | Jul 15, 2024 |
| Jul 15, 2024 | CConversion Class B Common Stockderivative10b5-1 | -81,731 | $0.00 | $0 | 0 | Jul 15, 2024 |
Related signals
Other insiders at ZUORA INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 32Weak | ZUORA INC | Peter Hirsch Chief Product & Tech Officer | $194k 19,469 shares | -45% | |
| 33Weak | ZUORA INC | Andrew M. Cohen CLO and Corp. Secretary | $225k 22,672 shares | -10% | |
| 20Weak | ZUORA INC | Matthew R Dobson Chief Accounting Officer | $29k 2,908 shares | -3% | |
| 38Weak | ZUORA INC | Peter Hirsch Chief Product & Tech Officer | $255k 25,664 shares | -37% | |
| 60Notable | ZUOsell ZUORA INC | John D Harkey Jr director | $2.3M 236,218 shares | -54% | |
| 31Weak | ZUORA INC | Peter Hirsch Chief Product & Tech Officer | $171k 18,855 shares | -49% | |
| 46Moderate | ZUORA INC | Andrew M. Cohen CLO and Corp. Secretary | $173k 20,773 shares | -11% | |
| 30Weak | ZUORA INC | Matthew R Dobson Chief Accounting Officer | $25k 2,994 shares | -4% | |
| 52Moderate | ZUORA INC | Peter Hirsch Chief Product & Tech Officer | $221k 26,432 shares | -41% | |
| 59Moderate | ZUORA INC | Todd McElhatton Chief Financial Officer | $433k 51,879 shares | -13% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.